1 |
Grant CS, Hay ID, Gough IR, et al : Local recurrence in papillary thyroid carcinoma: is extended of surgical resection important? Surgery. 1998 ; 104 : 954-962
|
2 |
Parker SL, Tong T, Bolden S, Wingo PA : 1997 Cancer statistics, 1997 CA Cancer J Clin. 47 : 5-27
|
3 |
Scheumann GF, Gimm O, et al : Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994 ; 18 : 559
|
4 |
Spies WG, Wojtowica CH, Spies SM, et al : Value of posttherapy whole body imaging in the evaluation of patients with thyroid carcinoma having undergone high dose therapy. Clin Med. 1989 ; 14 : 793-800
|
5 |
Vikram B, Strong EW, Shah JP, et al : Intraoperative radiotherapy in patients with recurrent head and neck cancer. Am J of Surg. 1985 ; 150(4) : 485-487
DOI
ScienceOn
|
6 |
Baskin HJ : Effect of postoperative treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer. Thyroid. 1994 ; 4 (3) : 239-242
DOI
PUBMED
ScienceOn
|
7 |
Tubiana M, Schlumberger M, Rougier P, et al : Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 1985 ; 55 : 794-804
DOI
ScienceOn
|
8 |
De Besi P, Busnardo B, Toso S, et al : Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. Journal of Endocrinological Investigation. 1991 ; 14(6) : 475-480
DOI
PUBMED
|
9 |
Kebebew E, Clark OH : Differentiated thyroid cancer: complete rational approach. World J of Surg. 2000 ; 24 (8) : 942-951
DOI
ScienceOn
|
10 |
Cady B, Rossi R, Silverman M, et al : Further evidence of the validity of risk group definition in differentiated thyroid carcinoma Surgery. 1985 ; 98 : 1171-1178
|
11 |
Coburn M, Teates D, Wanebo HJ : Recurrent thyroid cancer. Role of surgery versus radioactive iodine () Annals of Surg. 1994 ; 219 (6) : 587-593
|
12 |
Ronga G, fiorentino A, Paserio E, et al : Can iodine whole body scan be replaced by thyroiglobulin measurement in the post surgical follow-up differentiated thyroid carcinoma? J Nucl Med. 1990 ; 31 : 1766-1771
PUBMED
|
13 |
Degrossi OJ, Rozardos IB, Damilano S, et al : Serum thyroglobulin and whole body scanning as markers in the follow up of differentiated thyroid carcinomas. Medicina (B Aires). 1991 ; 51 : 291-295
PUBMED
|
14 |
Fatourechi V, Ray ID : Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases : including comments on the role of serum thyroglobulin monitoring in tumor surveillance. Seminars in Nucl. Med. 2000 ; 30 (2) : 107-114
|
15 |
Grunwald F, Menzel C, Fimmers R, Zamora PO, Biersack HJ : Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. J of Nucl Med. 1996 ; 37 (12) : 1962-1964
|
16 |
Adams S, Baum RP : Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors : Quarterly J of Nucl Med. 2000 ; 44(1) : 59-67
|
17 |
Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F : DeGroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiate thyroid cancer. J of Clin Endo & Meta. 1994 ; 79(1) : 98-105
DOI
|
18 |
Shimaoka K, Schoenfeld DA, Dewys WD, et al : A randomized trial ofdoxarubicin versus doxorubicin plus cisplatin in patients with advanced thyroid cancer. Cancer. 1985 ; 56 (9) : 2155-2160
DOI
ScienceOn
|
19 |
Mazzaferri EL, Jhiang SM : Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American J of Medicine. 1994 ; 97 : 418-428
DOI
ScienceOn
|